3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
34
Phase EARLY_PHASE1
6
Phase 1
5
Phase 3
4
Phase 2
4
Phase 4
2
Phase 2/3
1
Phase 1/2
1
Status
Completed
66
Unknown
27
Withdrawn
8
Terminated
7
Active not recruiting
3
Recruiting
2
Suspended
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other
2
Conditions
Breast Neoplasms
33
Neoplasms
16
Prostatic Neoplasms
15
Lung Neoplasms
11
Carcinoma, Hepatocellular
11
Multiple Myeloma
9
Colorectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Papillomavirus Infections
6
Pain, Postoperative
6
Neoplasm Metastasis
6
Liver Neoplasms
6
Leukemia, Myeloid, Acute
6
Stomach Neoplasms
5
Recurrence
5
Lymphoma, Non-Hodgkin
4
Kidney Neoplasms
4
Heart Failure
4
Glioma
4
Febrile Neutropenia
4
Carcinoma, Renal Cell
4
Brain Neoplasms
4
Warts
3
Vomiting
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Skin Neoplasms
3
Rectal Neoplasms
3
Pituitary Neoplasms
3
Interventions
Tirzepatide
1
Metformin
1
Liraglutide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Recruiting
×
Polycystic Ovary Syndrome
×
Clear all
NCT07326111
2026-01-08
PERIODS
University of Bonn
Phase 4
Recruiting
198 enrolled
NCT06742710
2025-05-29
LITOP
Peking University Third Hospital
Phase 4
Recruiting
890 enrolled